Figure 1: Overview of EMA guidelines related to the development and approval of biosimilars. Abbreviations: EMA, European Medicines Agency; GCSF, granulocyte colony-stimulating factor; GH, growth hormone; IFNα, interferon alpha; IFNβ, interferon beta. Figure 1 – Overview of EMA guidelines related to the development and approval of biosimilars